Poster presentation Title: Development and Characterization of SL-325, a DR3-Targeted, Antagonistic Antibody for the Treatment of IBD Presenter: Suresh de Silva, Ph.D., Shattuck’s Co-Chief ...
Shattuck Labs announces a poster presentation on SL-325 for inflammatory bowel disease at the 2025 Crohn’s and Colitis Congress. Shattuck Labs, Inc., a biotechnology company focused on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback